Kure Advisory’s IBM IBM Stock Holding History

Kure Advisory’s Portfolio IBM Stock Details IBM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,102	Closed	-$507K	–	79
2023 Q4	$507K	Sell	3,102 -7	-0.2%	-$1.06K	0.26%	46
2023 Q3	$436K	Buy	+3,109	New	+$442K	0.25%	51

Other funds holding IBM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Kure Advisory's IBM Position: Q1 2024 in Review

Kure Advisory sold out of IBM (IBM) in Q1 2024, closing a stake of 3,102 shares — an estimated $507K sold.

Kure Advisory first reported a position in IBM in Q3 2023 and held it in 2 quarters. The position peaked at $507K in Q4 2023. 2,802 funds tracked by Wall St. Rank hold IBM as of Q1 2024.

Kure Advisory reported no remaining IBM position as of Q1 2024 after selling out during the quarter.
Kure Advisory sold 3,102 IBM shares in Q1 2024, an estimated $507K.
Kure Advisory first reported a position in IBM in Q3 2023 and held it in 2 quarters.
Kure Advisory's IBM position peaked at $507K in Q4 2023.
2,802 funds tracked by Wall St. Rank held IBM as of Q1 2024.

Based on Kure Advisory's 13F filing for Q1 2024, filed 9 May 2024.